Patent · US Active

Methods and compositions for treating prostate cancer or inducing a humoral immune response against prostate cancer

US8840881B2 · kind B2 · utility

6Cited by
10References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 24, 2009
Grant dateSep 23, 2014
Priority date
Expiry dateDec 27, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/575
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to prostate cancer markers, compositions comprising such markers, and methods of using such markers to induce or increase an immune response against prostate cancer. An immune response against the markers correlates with an immune response, in particular a humoral immune response, against prostate cancer cells which immune response is preferably associated with prophylaxis of prostate cancer, treatment of prostate cancer, and/or amelioration of at least one symptom associated with prostate cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.